Gold Standard
Regenerative
Placenta-derived growth factor protocols are designed to release compounds gradually over several weeks. Placenta extract therapy is investigational and not FDA-approved for the treatment of any disease. Individual responses vary and some patients see no benefit.
The human placenta is one of the most powerful healing tissues in nature. It was designed to nourish and protect a developing baby. Placental extract therapy uses this source to provide a full range of healing molecules that work together to reduce inflammation, repair tissue, and restore cell function.
The biggest advantage of this therapy is speed. Placental extract contains growth factors that are ready to use right away. There is no waiting for cells to settle in and grow. Within 2 to 4 weeks, most patients notice less inflammation and better energy, much faster than stem cell therapy which can take 8 to 12 weeks.
Our implant system holds these healing compounds inside a small, body-safe pellet that releases them slowly over several weeks. This steady release keeps the healing signal active longer, reaches deeper into tissue, and means fewer clinic visits than a series of injections.
Placenta extract therapy is being investigated for its interactions with inflammatory processes across multiple body systems. It is investigational and not FDA-approved for the treatment of any specific disease. The areas below are those patients most often ask about, not conditions this therapy is approved or proven to treat.
Placenta-derived growth factors are being studied for their interaction with inflammatory signalling in the joint. Placenta extract is not FDA-approved for the treatment of osteoarthritis or any other joint condition. Individual responses vary.
Placental extract turns down the signals that cause inflammation while turning up the signals that calm the immune system. The slow-release implant keeps this balance active longer than a single injection would.
Amino acids and growth factors in the extract are being studied for their potential role in the body's energy production and metabolic function. These effects are not established, results vary, and this use is investigational and not FDA-approved.
Growth factors in the extract are studied for their role in collagen and elastin signalling. Some patients report changes in skin texture and hydration; others report no change. These outcomes are self-reported and not established by controlled trials.
A 5 to 10 minute minimally invasive procedure. No cuts. Most patients return to normal activity the same day.
We run baseline lab tests to check liver function, inflammation levels, and metabolic health. This confirms you are a good candidate and gives us a starting point to track your progress. The treating provider also reviews any prior treatments and your current health conditions.
A small area, usually the upper arm, hip, or abdomen, is cleaned and numbed with a topical anesthetic. This takes just a few minutes.
A small applicator places the implant pellet just under the skin. No stitches are needed. A small bandage covers the site. Most patients feel little to no discomfort during or after the procedure.
You can return to your normal routine the same day. Avoid intense heat and hard exercise for the first 24 hours. Between days 2 and 7, the implant begins releasing healing compounds and anti-inflammatory activity starts.
A second implant may be placed 1 to 2 weeks later if the treating provider recommends it. After that, follow-up treatments are scheduled every 3 to 4 weeks based on how you are responding and what your goals are.
Not sure whether this applies to your case? Candidacy is determined by medical review of your history and imaging, not by a form. The consultation is complimentary.
See If You QualifyThis is our fastest-acting regenerative protocol. The growth factors are ready to work from day one, with no waiting for cells to settle in.
The implant begins releasing its growth factor payload. Patients who respond often describe early changes in energy or discomfort during this period. Others notice nothing yet, and some notice nothing at all.
This is the window in which the implant's release rate is highest. Patients who respond typically report their most noticeable changes during this period, though the degree of change varies widely and some patients report none.
Release tapers over this window. Patients who respond commonly report changes in movement or skin quality here. Your physician will assess whether returning to full-intensity activity is appropriate for your case.
The implant fully dissolves during this period. Long-term outcomes after placenta extract protocols are not established by controlled trials, and durability of any response varies considerably between individuals.
Placenta extract therapy uses concentrated growth factors derived from ethically sourced placental tissue to support immune modulation, tissue repair, and systemic regeneration. All donor tissue undergoes rigorous screening and GMP-certified processing.
All placental tissue is donor-screened, GMP-processed, and tested for sterility before use. The products undergo comprehensive quality testing including screening for infectious diseases. A full medical evaluation is required before treatment.
Placenta extract therapy is evaluated for systemic inflammation, immune modulation, chronic degenerative conditions, and tissue support. It is often used as part of a broader regenerative protocol alongside stem cell or exosome therapy.
Placenta extract therapy is growth-factor-focused rather than cell-based. It delivers a concentrated package of signaling molecules and growth factors without transplanting living cells. Many physicians combine both approaches for complementary benefits.
Many patients notice changes within 4 to 8 weeks. Results vary depending on condition severity, overall health, and whether placenta extract is combined with other regenerative therapies in the protocol.
Connect with our coordination team to explore whether placenta extract therapy may be available for your condition and goals through an independent provider.
CHECK IF YOU QUALIFY →Medically reviewed by Dr. Karla Chavira, MD, Regenerative Medicine Physician and CEO of CMCells (Cédula Profesional on file).
Last reviewed: July 2026